fluoxetine has been researched along with Shock in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Methylene blue may have utility in the treatment of distributive shock resulting from poisoning refractory to standard vasopressor therapy." | 7.80 | Methylene blue used in the treatment of refractory shock resulting from drug poisoning. ( Braitberg, G; Fisher, J; Graudins, A; Taori, G, 2014) |
| " Methylene blue may have utility in the treatment of distributive shock resulting from poisoning refractory to standard vasopressor therapy." | 3.80 | Methylene blue used in the treatment of refractory shock resulting from drug poisoning. ( Braitberg, G; Fisher, J; Graudins, A; Taori, G, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, J | 1 |
| Taori, G | 1 |
| Braitberg, G | 1 |
| Graudins, A | 1 |
1 other study available for fluoxetine and Shock
| Article | Year |
|---|---|
Methylene blue used in the treatment of refractory shock resulting from drug poisoning.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antidotes; Antipsychotic Agents; B | 2014 |